A denial can cost a patient timely, important care, but earn the contractor denying the care some money. That is the setup behind the Medicare AI program now operating in Washington. The Seattle Times reports that one contractor denied 53 percent of the requests it reviewed. Newly released records also explain the incentive behind that number.
Medicare launched the pilot, called WISeR, on Jan. 1 in Washington and five other states. CMS contracted with third-party tech companies to approve or deny requests for certain medical services, and those companies use “enhanced technology,” such as AI and machine learning. Prior authorization, in short, means a patient needs approval before care can happen.
The first-quarter records show a stark gap. Virtix denied 53 percent of the Washington requests it reviewed. In Arizona, a different contractor reviewed 14,300 requests and denied fewer than 20 percent. Same program. Same quarter. Virtix says its denial rate is now trending closer to 30 percent. Progress, perhaps, but patients who waited through the first quarter do not get that time back.
Contractors keep a portion of the money they save Medicare. CMS’s own financial analysts saw the problem coming. A memo in the released documents says participants are paid based on claims denied. As a result, they warned, “model participants will have an incentive to deny as many claims as possible.” Rarely does a payment structure come with its own warning label.
Can Medicare AI Review Stay Neutral?
That memo raises a hard question: can AI medical referral review stay neutral when a contractor’s payment depends on saying no? Asking for neutrality while paying by the denial is, at best, an optimistic design. Patients have faced this tension before, whenever profit motives shape medical care. This time, however, the tension comes with a number, and with patients whose care hangs on it.
Keith Magnuson, 83, of Seattle, is one of them. He has lumbar spinal stenosis, a condition that has cut his walking from 6 miles a day to about 100 yards. One part of his treatment needs approval from the WISeR program.
Since January, the program has denied his back-pain treatment three times. Only after the third denial did he learn who, or what, had been saying no. The decision came from AI, not a person. His doctor has since requested a peer-to-peer review with Virtix, and independent pain physicians told The Seattle Times the denied injection is a reasonable part of his procedure.
Delay is where a denial becomes an injury. Delayed treatment sits at the center of many medical malpractice claims, because a condition left waiting can worsen past the point where timely care would have helped. Every week a request sits in review is a week that can happen.
Pay for denials, and denials arrive right on schedule. For Washington patients, Medicare AI turned that logic into waiting. The only open question is how long CMS lets it continue.
